ENDOCRINE EFFECTS OF COMBINATION ANTIOESTROGEN AND LH-RH AGONIST THERAPY IN PREMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引:25
作者
WALKER, KJ [1 ]
WALKER, RF [1 ]
TURKES, A [1 ]
ROBERTSON, JFR [1 ]
BLAMEY, RW [1 ]
GRIFFITHS, K [1 ]
NICHOLSON, RI [1 ]
机构
[1] CITY HOSP,DEPT SURG,NOTTINGHAM NG5 1PB,ENGLAND
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 04期
关键词
D O I
10.1016/0277-5379(89)90200-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:651 / 654
页数:4
相关论文
共 37 条
[1]  
BEEX L, 1981, CANCER TREAT REP, V65, P179
[2]  
BERRETA G, 1982, ROLE TAMOXIFEN BREAS, P113
[3]   THE PHARMACOLOGY AND CLINICAL USES OF TAMOXIFEN [J].
FURR, BJA ;
JORDAN, VC .
PHARMACOLOGY & THERAPEUTICS, 1984, 25 (02) :127-205
[4]   PLASMA HORMONES IN PATIENTS WITH ADVANCED BREAST-CANCER TREATED WITH TAMOXIFEN [J].
GOLDER, MP ;
PHILLIPS, MEA ;
FAHMY, DR ;
PREECE, PE ;
JONES, V ;
HENK, JM ;
GRIFFITHS, K .
EUROPEAN JOURNAL OF CANCER, 1976, 12 (09) :719-723
[5]  
HARVEY HA, 1987, HORMONAL MANIPULATIO, P321
[6]  
HOOGSTRATEN B, 1982, CANCER RES, V42, P4788
[7]   BIODEGRADABLE POLYMERS FOR THE SUSTAINED-RELEASE OF PEPTIDES [J].
HUTCHINSON, FG ;
FURR, BJA .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1985, 13 (02) :520-523
[8]   RANDOMIZED CLINICAL-TRIAL OF DIETHYLSTILBESTROL VERSUS TAMOXIFEN IN POST-MENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER [J].
INGLE, JN ;
AHMANN, DL ;
GREEN, SJ ;
EDMONSON, JH ;
BISEL, HF ;
KVOLS, LK ;
NICHOLS, WC ;
CREAGAN, ET ;
HAHN, RG ;
RUBIN, J ;
FRYTAK, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (01) :16-21
[9]  
KLIJN JGM, 1988, PROGR CANCER RES THE, V35, P365
[10]  
KLIJN JGM, 1984, LHRH ITS ANALOGUES, P425